» Articles » PMID: 38881258

Efficacy of Biphasic Calcium Phosphate Ceramic With a Needle-Shaped Surface Topography Versus Autograft in Instrumented Posterolateral Spinal Fusion

Overview
Specialty Orthopedics
Date 2024 Jun 17
PMID 38881258
Authors
Affiliations
Soon will be listed here.
Abstract

Study Design: A multicenter randomized controlled noninferiority trial with intrapatient comparisons.

Objective: The aim of this study was to determine noninferiority of a slowly resorbable biphasic calcium phosphate with submicron microporosity (BCP<μm, MagnetOs Granules) as an alternative for autograft in instrumented posterolateral fusion (PLF).

Summary Of Background Data: Successful spinal fusion with a solid bone bridge between the vertebrae is traditionally achieved by grafting with autologous iliac bone. However, the disadvantages of autografts and unsatisfactory fusion rates have prompted the exploration of alternatives, including ceramics. Nevertheless, clinical evidence for the standalone use of these materials is limited.

Methods: Adults indicated for instrumented PLF (1 to 6 levels) were enrolled at 5 participating centers. After bilateral instrumentation and fusion-bed preparation, the randomized allocation side (left or right) was disclosed. Per segment 10 cc of BCP<μm granules (1 to 2 mm) were placed in the posterolateral gutter on one side and 10 cc autograft on the contralateral side. Fusion was systematically scored on 1-year follow-up CT scans. The study was powered to detect >15% inferiority with binomial paired comparisons of the fusion performance score per treatment side.

Results: Of the 100 patients (57 ± 12.9 y, 62% female), 91 subjects and 128 segments were analyzed. The overall posterolateral fusion rate per segment (left and/or right) was 83%. For the BCP<μm side only the fusion rate was 79% versus 47% for the autograft side (difference of 32 percentage points, 95% CI, 23-41). Analysis of the primary outcome confirmed the noninferiority of BCP<μm with an absolute difference in paired proportions of 39.6% (95% CI, 26.8-51.2; p < 0.001).

Conclusion: This clinical trial demonstrates noninferiority and indicates superiority of MagnetOs Granules as a standalone ceramic when compared to autograft for posterolateral spinal fusion. These results challange the belief that autologous bone is the most optimal graft material.

References
1.
Glassman S, Carreon L, Djurasovic M, Campbell M, Puno R, Johnson J . RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age. Spine (Phila Pa 1976). 2008; 33(26):2843-9. DOI: 10.1097/BRS.0b013e318190705d. View

2.
Ostelo R, Deyo R, Stratford P, Waddell G, Croft P, Von Korff M . Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine (Phila Pa 1976). 2008; 33(1):90-4. DOI: 10.1097/BRS.0b013e31815e3a10. View

3.
Mariscal G, Nunez J, Barrios C, Domenech-Fernandez P . A meta-analysis of bone morphogenetic protein-2 versus iliac crest bone graft for the posterolateral fusion of the lumbar spine. J Bone Miner Metab. 2019; 38(1):54-62. DOI: 10.1007/s00774-019-01025-9. View

4.
Cammisa Jr F, Lowery G, Garfin S, Geisler F, Klara P, McGuire R . Two-year fusion rate equivalency between Grafton DBM gel and autograft in posterolateral spine fusion: a prospective controlled trial employing a side-by-side comparison in the same patient. Spine (Phila Pa 1976). 2004; 29(6):660-6. DOI: 10.1097/01.brs.0000116588.17129.b9. View

5.
Delawi D, Dhert W, Castelein R, Verbout A, Oner F . The incidence of donor site pain after bone graft harvesting from the posterior iliac crest may be overestimated: a study on spine fracture patients. Spine (Phila Pa 1976). 2007; 32(17):1865-8. DOI: 10.1097/BRS.0b013e318107674e. View